MUT056399

a FabI inhibitor with antibacterial activity; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Staphylococcal Infections 10/01/2011 - "These properties support MUT056399 as a very promising candidate for a novel drug to treat severe staphylococcal infections."
2.	Infections 10/01/2011 - "In the nonneutropenic murine thigh infection model, the same treatment with MUT056399 reduced the bacterial multiplication of MSSA and MRSA in the thighs of immunocompetent mice. " 10/01/2011 - "In vivo, MUT056399, administered subcutaneously, protected mice from a lethal systemic infection induced by MSSA, MRSA, and vancomycin-intermediate S. "

1.	Vancomycin